ABX PENTRA 400: LIPOPROTEINS— 510(k) K060854

Substantially Equivalent

Horiba Abx

FDA 510(k) clearance K060854 for ABX PENTRA 400: LIPOPROTEINS, Substantially Equivalent on 2006-08-24. Applicant: Horiba Abx.

Clearance details

Applicant: Horiba Abx
Product code: Code JIT
Advisory panel: Clinical Chemistry
Date received: 2006-03-29
Decision date: 2006-08-24
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Montpellier, FR

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.